Volume 84, Issue 4, Pages (October 2013)

Slides:



Advertisements
Similar presentations
Date of download: 6/28/2016 From: Sensitivity and Specificity of a Single Emergency Department Measurement of Urinary Neutrophil Gelatinase–Associated.
Advertisements

Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Combining Functional and Tubular Damage Biomarkers.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Diagnostic and Prognostic Stratification in the.
Volume 68, Issue 5, Pages (November 2005)
Volume 66, Issue 4, Pages (October 2004)
Volume 54, Issue 2, Pages (August 1998)
Volume 81, Issue 5, Pages (March 2012)
Volume 152, Issue 5, Pages (November 2017)
Urinary, Plasma, and Serum Biomarkers’ Utility for Predicting Acute Kidney Injury Associated With Cardiac Surgery in Adults: A Meta-analysis  Julie Ho,
Propofol-related green urine
Sushrut S. Waikar, Venkata S. Sabbisetti, Joseph V. Bonventre 
Volume 89, Issue 4, Pages (April 2016)
Volume 89, Issue 6, Pages (June 2016)
Volume 68, Issue 5, Pages (November 2005)
Edward D. Siew, Andrew Davenport  Kidney International 
Summary of Recommendation Statements
Blaithin A. McMahon, Patrick Thomas Murray  Kidney International 
C-reactive protein and dialysis access
Biomarkers in Nephrology: Core Curriculum 2013
Volume 77, Issue 9, Pages (May 2010)
The cardiac surgery–associated neutrophil gelatinase-associated lipocalin (CSA-NGAL) score: A potential tool to monitor acute tubular damage  Hilde R.H.
Volume 60, Issue 2, Pages (August 2001)
Pharmacokinetics and pharmacodynamics of oral tolvaptan in patients with varying degrees of renal function  Susan E. Shoaf, Patricia Bricmont, Suresh.
C-reactive protein and dialysis access
Volume 85, Issue 4, Pages (April 2014)
Volume 84, Issue 1, Pages (July 2013)
Volume 73, Issue 4, Pages (February 2008)
Volume 80, Issue 4, Pages (August 2011)
Combination of Two Urinary Biomarkers Predicts Acute Kidney Injury After Adult Cardiac Surgery  Daisuke Katagiri, MD, Kent Doi, MD, PhD, Kenjiro Honda,
Volume 78, Issue 12, Pages (December 2010)
Volume 80, Issue 7, Pages (October 2011)
Aadil Kakajiwala, MBBS, Ji Young Kim, PhD, John Z
Neutrophil gelatinase–associated lipocalin: A promising biomarker for detecting cardiac surgery–associated acute kidney injury  Dinna N. Cruz, MD, Claudio.
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
How to interpret the eGFR in patients with small body surface area
Volume 66, Issue 4, Pages (October 2004)
Volume 78, Issue 9, Pages (November 2010)
Comorbidity and confounding in end-stage renal disease
Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought  Nicolas Rognant, Maurice Laville  Kidney.
Volume 76, Issue 8, Pages (October 2009)
Renal risk scores: Progress and prospects
Volume 76, Issue 3, Pages (August 2009)
Volume 85, Issue 2, Pages (January 2014)
Volume 75, Issue 9, Pages (May 2009)
Volume 81, Issue 5, Pages (March 2012)
The promise of biomarkers for personalized renal cancer care
Volume 80, Issue 12, Pages (December 2011)
Kai Singbartl, John A. Kellum  Kidney International 
Volume 77, Issue 8, Pages (April 2010)
Volume 73, Issue 5, Pages (March 2008)
Volume 74, Issue 8, Pages (October 2008)
Volume 87, Issue 5, Pages (May 2015)
Volume 76, Issue 1, Pages (July 2009)
Volume 78, Issue 5, Pages (September 2010)
Volume 79, Issue 10, Pages (May 2011)
Volume 76, Issue 8, Pages (October 2009)
Perioperative Acute Kidney Injury
Urinary biomarkers in the early diagnosis of acute kidney injury
Volume 77, Issue 6, Pages (March 2010)
Does equal care give equal outcomes?
Volume 80, Issue 10, Pages (November 2011)
Volume 70, Issue 7, Pages (October 2006)
Charles A. Herzog  Kidney International 
The hypothesis that abnormal BH4 metabolism impairs kidney function
Volume 76, Issue 1, Pages 8-10 (July 2009)
Pediatric acute kidney injury: The use of the RIFLE criteria
Volume 81, Issue 8, Pages (April 2012)
Volume 83, Issue 5, Pages (May 2013)
Volume 78, Issue 5, Pages (September 2010)
Volume 79, Issue 10, Pages (May 2011)
Presentation transcript:

Volume 84, Issue 4, Pages 786-794 (October 2013) Distinct injury markers for the early detection and prognosis of incident acute kidney injury in critically ill adults with preserved kidney function  Edward D. Siew, Lorraine B. Ware, Aihua Bian, Ayumi Shintani, Svetlana K. Eden, Nancy Wickersham, Ben Cripps, T. Alp Ikizler  Kidney International  Volume 84, Issue 4, Pages 786-794 (October 2013) DOI: 10.1038/ki.2013.174 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Study scheme. AKI, acute kidney injury; ICU, intensive care unit. Kidney International 2013 84, 786-794DOI: (10.1038/ki.2013.174) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 Box-plot of changes in serum creatinine between acute kidney injury (AKI) cases and non-AKI controls. The first, second, and third panels represent the baseline serum creatinine, the highest serum creatinine within 24h after biomarker measurement, and the highest serum creatinine within 24–48h of biomarker measurement, respectively. Creatinine measurements were ordered by point-of-care personnel. P-values <0.05 denote statistical significance. Kidney International 2013 84, 786-794DOI: (10.1038/ki.2013.174) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Box-plot of levels of urine cystatin C (uCysC) urine neutrophil gelatinase–associated lipocalin (uNGAL) and L-type fatty acid–binding protein (L-FABP) grouped by acute kidney injury (AKI) versus non-AKI status. Levels are adjusted for urine creatinine values. P-values <0.0273 denote statistical significance. Kidney International 2013 84, 786-794DOI: (10.1038/ki.2013.174) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 4 Discrimination of AKI versus non-AKI status within 48 hours of urine neutrophil gelatinase–associated lipocalin (uNGAL) and uL-FABP measurement. (a) Area under the receiver-operating curves for uNGAL, L-type fatty acid–binding protein (L-FABP), and both biomarkers combined for discriminating any future acute kidney injury (AKI) from non-AKI status. (b) Area under the receiver-operating curves for urine NGAL, L-FABP, and both biomarkers combined for discriminating future AKIN stages II and III from non-AKI status. AUC, area under the curve. Kidney International 2013 84, 786-794DOI: (10.1038/ki.2013.174) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 5 Box-plots of levels of urine neutrophil gelatinase–associated lipocalin (uNGAL) and L-type fatty acid–binding protein (L-FABP) grouped according to whether patients experienced the composite outcome of dialysis or mortality.P-values <0.0273 denote statistical significance. Kidney International 2013 84, 786-794DOI: (10.1038/ki.2013.174) Copyright © 2013 International Society of Nephrology Terms and Conditions